Request Demo
Last update 16 Aug 2025
CAR-T Cells Targeting CD30(Shandong Qilu Cell Therapy Engineering Technology)
Last update 16 Aug 2025
Overview
Basic Info
Drug Type CAR-T |
Synonyms CD30 CAR-T(Shandong Qilu Cell Therapy Engineering Technology) |
Target |
Action modulators |
Mechanism CD30 modulators(Tumor necrosis factor receptor superfamily member 8 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CAR-T Cells Targeting CD30(Shandong Qilu Cell Therapy Engineering Technology)NCT07048353
Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor Gene Modified T Cells Targeting CD30 in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
100 Clinical Results associated with CAR-T Cells Targeting CD30(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
100 Translational Medicine associated with CAR-T Cells Targeting CD30(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
100 Patents (Medical) associated with CAR-T Cells Targeting CD30(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
100 Deals associated with CAR-T Cells Targeting CD30(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Lymphoma | Phase 1 | China | 28 Jul 2025 | |
| CD30 Positive Gray Zone Lymphoma | Phase 1 | China | 28 Jul 2025 | |
| Peripheral T-Cell Lymphoma | Phase 1 | China | 28 Jul 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free